Depixus
Paris
About Depixus
Depixus includes a Full genome analysis, which necessitates technologies capable of reading DNA, RNA, and their base changes. The dynamics of this cannot be captured with single-molecule precision by today's sequencing technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $38.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: depixus.com
- Phone: +33 (0)9 72 48 20 89
Industries & Categories
Biotechnology, Genetics, Medical
Social Profiles
Canonical: https://fsome.com/organization/depixus-84149 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.